Physician profile
Jacqueline Bohn
NPI 1104357540
$1,479.91
in general payments reported to CMS, 2019-2025
9 companies · $93.08 in 2025
The $93.08 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2023: $149 · 2024: $1,116 · 2025: $93.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $357.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,057.96 | 2024 | |
| Glaxosmithkline, LLC. | $164.66 | 2021-2024 | |
| Immunogen, INC. | $125.43 | 2023 | Elahere |
| Eisai INC. | $31.09 | 2025 | |
| Daiichi Sankyo INC. | $25.19 | 2025 | Enhertu |
| Ethicon US, LLC | $23.18 | 2023 | Ethicon, Echelon Flex |
| Merck Sharp & Dohme LLC | $22.39 | 2025 | Keytruda |
| Myriad Genetic Laboratories, INC. | $15.60 | 2024 | Myrisk |
| Abbvie INC. | $14.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Bohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.